ENCOMPASS HEALTH CORPORATION
Income flow
Annual
EHC 10-K Income StatementPeriod 2025-12-31Source 10-K
As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.
Revenue mix
2025-12-31 · 10-K · USD
By activity
- Inpatient$5.8B97.0%
- Other$179M3.0%
Capital & dividends
YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.68%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.0.86%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0.76PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.12.7%Shares outTotal shares currently outstanding (issued and not retired).98.7MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).97.7M
Upcoming dividend
- Ex-dividend
- 2026-10-01
- Next pay
- 2026-10-15
- Last cash
- 0.21 · 2026-10-01
Annual DPS
0.875119
0.89120
0.89121
0.802822
0.623
0.4724
0.725
0.7826
Shares outstanding (as-filed)
102.2M24
102.2M25
Stock splits
- 1257:10002022-07-01
Recent payments
0.1512/22
0.1503/23
0.1506/23
0.1509/23
0.1512/23
0.1503/24
0.1507/24
0.1710/24
0.1701/25
0.1704/25
0.1707/25
0.1910/25
0.1901/26
0.1904/26
0.1907/26
0.2110/26
Valuation
Trailing PE 19.0 (2025-12-31)
Fiscal PE2
| Period | EPS | Close | PE |
|---|---|---|---|
| 2025-12-31 | 5.54 | 105.36 | 19.0 |
| 2024-12-31 | 4.46 | 91.09 | 20.4 |
PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.